Millipore Sigma Vibrant Logo

567022 InSolution™ Simvastatin, Sodium Salt - Calbiochem

View Products on Sigmaaldrich.com
567022
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

Empirical Formula
C₂₅H₃₉O₆ •Na

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
567022-5MG
Verifica della disponibilità in corso...
Disponibilità limitata
Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      Bottiglia di vetro 5 mg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      Richiedi il prezzo
      Description
      OverviewCarboxylate form of Simvastatin (Cat. No. 567020) that is active in whole cells and in cell-free assays. A lipophilic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor that blocks Ras function through inhibition of farnesylation. Also inhibits glucose-induced Ca2+-signaling and insulin secretion by blocking L-type Ca2+ channels in rat islet β-cells. Inhibits cell proliferation of human smooth muscle cells. The solid form of this compound (Cat. No. 567021) is also available.
      Catalogue Number567022
      Brand Family Calbiochem®
      SynonymsL-Type Calcium Channel Blocker VI
      References
      ReferencesYada, T., et al. 1999. Br. J. Pharmacol. 126, 1205.
      Clutterbuck, R.D., et al. 1998. Br. J. Haematol. 102, 522.
      Yokoyama, K., et al. 1998. Mol. Biochem. Parasitol. 94, 87.
      Negre-Aminou, P., et al. 1997. Biochim. Biophys. Acta 1345, 259.
      Vrtovsnik, F., et al. 1997. Kidney Int. 52, 1016.
      Keyomarsi, K., et al. 1991. Cancer Res. 51, 3602.
      Product Information
      FormLiquid
      FormulationA 10 mM (5 mg/1.09 ml) solution of Simvastatin, Sodium Salt (Cat. No. 567021) in H₂O.
      Hill FormulaC₂₅H₃₉O₆ •Na
      Chemical formulaC₂₅H₃₉O₆ •Na
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      ApplicationInSolution™ Simvastatin, Sodium Salt, 101314-97-0, is provided as a 10 mM in H₂O. It is the carboxylate form of Simvastatin that is active in whole cells and in cell-free preparations.
      Biological Information
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 36/38

      Irritating to eyes and skin.
      S PhraseS: 26

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Irritant
      Storage ≤ -70°C
      Protect from Light Protect from light
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      567022-5MG 04055977267129

      Documentation

      InSolution™ Simvastatin, Sodium Salt - Calbiochem MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      InSolution™ Simvastatin, Sodium Salt - Calbiochem Certificati d'Analisi

      TitoloNumero di lotto
      567022

      Riferimenti bibliografici

      Panoramica delle referenze
      Yada, T., et al. 1999. Br. J. Pharmacol. 126, 1205.
      Clutterbuck, R.D., et al. 1998. Br. J. Haematol. 102, 522.
      Yokoyama, K., et al. 1998. Mol. Biochem. Parasitol. 94, 87.
      Negre-Aminou, P., et al. 1997. Biochim. Biophys. Acta 1345, 259.
      Vrtovsnik, F., et al. 1997. Kidney Int. 52, 1016.
      Keyomarsi, K., et al. 1991. Cancer Res. 51, 3602.

      Brochure

      Titolo
      New Products: Volume 3, 2012
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision03-April-2012 JSW
      SynonymsL-Type Calcium Channel Blocker VI
      DescriptionCarboxylate form of Simvastatin (Cat. No. 567020) that is active in whole cells and in cell-free assays. A lipophilic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor that blocks Ras function through inhibition of farnesylation. Also inhibits glucose-induced Ca2+-signaling and insulin secretion by blocking L-type Ca2+ channels in rat islet β-cells. Inhibits cell proliferation of human smooth muscle cells. The solid form of Simvastatin, Sodium Salt (Cat. No. 567021) is also available.
      FormLiquid
      FormulationA 10 mM (5 mg/1.09 ml) solution of Simvastatin, Sodium Salt (Cat. No. 567021) in H₂O.
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₂₅H₃₉O₆ •Na
      Structure formulaStructure formula
      Purity≥95% by HPLC
      Storage Protect from light
      Avoid freeze/thaw
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Toxicity Irritant
      ReferencesYada, T., et al. 1999. Br. J. Pharmacol. 126, 1205.
      Clutterbuck, R.D., et al. 1998. Br. J. Haematol. 102, 522.
      Yokoyama, K., et al. 1998. Mol. Biochem. Parasitol. 94, 87.
      Negre-Aminou, P., et al. 1997. Biochim. Biophys. Acta 1345, 259.
      Vrtovsnik, F., et al. 1997. Kidney Int. 52, 1016.
      Keyomarsi, K., et al. 1991. Cancer Res. 51, 3602.